Agree Orioles. Though I think the deal will be on a PH2b NASH to get the higher dosing tested before a PH3 (& eventual market launch ) Anyway concur. Do you think (on this pharma deal) that it's unreasonable to expect a USD$350mio market cap before the close of 2018?
- Forums
- ASX - By Stock
- IMC
- Next Catalyst
IMC
immuron limited
Add to My Watchlist
0.00%
!
3.9¢
Next Catalyst, page-2
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
